Lutris Pharma
Israel
Established in 2015
1-10 employees
Metallurgy, Chemicals, Rubber & Plastics · Tel Aviv-Yafo
Sector / Industry
Metallurgy, Chemicals, Rubber & Plastics
Company description
Lutris Pharma is developing the topical B-Raf inhibitor LUT014, a proprietary small molecule allowing administration of epidermal growth factor receptor (EGFR) inhibitors to patients without the interruptions caused by typical cutaneous side effects. ...
Products and services
Metallurgy, Chemicals, Rubber & Plastics
PharmaceuticalsHS 30
Promotional material
To view this content
Sign in